GREM2 Human

GREM2 Human Recombinant
Cat. No.
BT12401
Source
E.coli.
Synonyms
CKTSF1B2, DAND3, PRDC, Gremlin-2, Cysteine knot superfamily 1, BMP antagonist 2, DAN domain family member 3, Protein related to DAN and cerberus, GREM2.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 85% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

GREM2 Human Recombinant produced in E. coli is a single polypeptide chain containing 170 amino acids (22-168) and having a molecular mass of 19kDa. GREM2 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
GREM2, a member of the bone morphogenetic protein (BMP) antagonist family, plays a crucial role in organ development, body patterning, and cell specialization. As a BMP antagonist, GREM2, similar to BMPs, possesses cystine knots and typically forms homodimers and heterodimers. Belonging to the cerberus and dan (CAN) subfamily of BMP antagonists, GREM2 is characterized by a C-terminal cystine knot with an 8-membered ring structure.
Description
Recombinant human GREM2, produced in E. coli, is a single polypeptide chain consisting of 170 amino acids (residues 22-168) with a molecular weight of 19 kilodaltons (kDa). The protein includes a 23 amino acid His-tag fused at the N-terminus and is purified using proprietary chromatographic methods.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
The GREM2 solution is provided at a concentration of 1 milligram per milliliter (mg/ml) and contains 20 millimolar (mM) Tris-HCl buffer at a pH of 8.0, 0.4 molar (M) Urea, and 10% glycerol.
Stability
For short-term storage (up to 2-4 weeks), keep refrigerated at 4 degrees Celsius. For extended storage, freeze at -20 degrees Celsius. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is determined by SDS-PAGE analysis and exceeds 85%.
Synonyms
CKTSF1B2, DAND3, PRDC, Gremlin-2, Cysteine knot superfamily 1, BMP antagonist 2, DAN domain family member 3, Protein related to DAN and cerberus, GREM2.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSRKNRPAG AIPSPYKDGS SNNSERWQHQ IKEVLASSQE ALVVTERKYL KSDWCKTQPL RQTVSEEGCR SRTILNRFCY GQCNSFYIPR HVKKEEESFQ SCAFCKPQRV TSVLVELECP GLDPPFRLKK IQKVKQCRCM SVNLSDSDKQ.

Product Science Overview

Structure and Function

GREM2 is synthesized as a 168 amino acid monomer and is biologically active as a disulfide-linked homodimer. The protein has six conserved cysteine residues that form a cysteine knot, a structural motif that is crucial for its function. Additionally, GREM2 has two extra cysteine residues located in the loops of the cysteine knot .

The primary function of GREM2 is to inhibit BMP activity. This inhibition is essential for various developmental processes, including osteoblast differentiation and osteogenesis. By antagonizing BMPs, GREM2 helps regulate the balance between bone formation and resorption, which is crucial for maintaining bone health .

Biological Activity

Recombinant human GREM2 has been shown to inhibit BMP-4-induced activity in MC3T3-E1 mouse preosteoblast cells. The effective dose (ED50) for this inhibition ranges from 0.03 to 0.12 μg/mL . This inhibitory effect underscores the protein’s role in regulating bone formation and highlights its potential therapeutic applications in bone-related disorders.

Genetic Associations

Recent genome-wide association studies (GWAS) have identified GREM2 as a novel susceptibility gene for trabecular volumetric bone mineral density (BMD). Variants in the GREM2 gene have been associated with low BMD, particularly in the spine, femoral neck, and total hip. These findings suggest that GREM2 plays a significant role in bone health and may be a potential target for osteoporosis treatment .

Clinical Implications

Given its role in bone formation and regulation, GREM2 has potential therapeutic applications in treating bone-related disorders such as osteoporosis. By modulating BMP activity, GREM2 could help restore the balance between bone formation and resorption, thereby improving bone density and reducing the risk of fractures .

Storage and Stability

Recombinant human GREM2 is typically lyophilized from a 0.2 μm filtered solution in HCl and should be reconstituted at 500 μg/mL in 4 mM HCl. The protein is stable for 12 months when stored at -20 to -70°C and for 1 month at 2 to 8°C under sterile conditions after reconstitution. It is important to avoid repeated freeze-thaw cycles to maintain its stability and activity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.